标题
A Practical Guide to the Treatment of Dravet Syndrome with Anti-Seizure Medication
作者
关键词
-
出版物
CNS DRUGS
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-02-14
DOI
10.1007/s40263-022-00898-1
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Dravet syndrome
- (2021) Lieven Lagae CURRENT OPINION IN NEUROLOGY
- A critical evaluation of fenfluramine hydrochloride for the treatment of Dravet syndrome
- (2021) An-Sofie Schoonjans et al. Expert Review of Neurotherapeutics
- The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial
- (2021) Anthony Marson et al. LANCET
- A systematic review of adults with Dravet syndrome
- (2021) Arunan Selvarajah et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Stiripentol in the treatment of adults with focal epilepsy- a retrospective analysis
- (2021) L. Habermehl et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Results From an Italian Expanded Access Program on Cannabidiol Treatment in Highly Refractory Dravet Syndrome and Lennox–Gastaut Syndrome
- (2021) Luigi Francesco Iannone et al. Frontiers in Neurology
- Add‐on cannabidiol in patients with Dravet syndrome: Results of a long‐term open‐label extension trial
- (2021) Ingrid E. Scheffer et al. EPILEPSIA
- Efficacy, tolerability, and retention of fenfluramine for the treatment of seizures in patients with Dravet syndrome: Compassionate use program in Germany
- (2021) Adam Strzelczyk et al. EPILEPSIA
- Defining Dravet syndrome: An essential pre‐requisite for precision medicine trials
- (2021) Wenhui Li et al. EPILEPSIA
- The long‐term efficacy of cannabidiol in the treatment of refractory epilepsy
- (2021) Sandip Patel et al. EPILEPSIA
- Aggravation of valproic acid induced thrombocytopenia after the introduction of fenfluramine, a case report
- (2021) A. Schoonjans et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Fenfluramine significantly reduces day‐to‐day seizure burden by increasing number of seizure‐free days and time between seizures in patients with Dravet syndrome: A time‐to‐event analysis
- (2021) Joseph Sullivan et al. EPILEPSIA
- Epidemiology, healthcare resource use, and mortality in patients with probable Dravet syndrome: A population-based study on German health insurance data
- (2021) Susanne Schubert-Bast et al. EPILEPSY & BEHAVIOR
- Early diagnosis and experimental treatment with fenfluramine via the Investigational New Drug mechanism in a boy with Dravet syndrome and recurrent status epilepticus
- (2021) Sara Trowbridge et al. EPILEPTIC DISORDERS
- Impact of fenfluramine on the expected SUDEP mortality rates in patients with Dravet syndrome
- (2021) J. Helen Cross et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Genetics and gene therapy in Dravet syndrome
- (2021) Norimichi Higurashi et al. EPILEPSY & BEHAVIOR
- Dravet Syndrome: A Review of Current Management
- (2020) James W. Wheless et al. PEDIATRIC NEUROLOGY
- Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome
- (2020) Ian Miller et al. JAMA Neurology
- Successful use of fenfluramine in nonconvulsive status epilepticus of Dravet syndrome
- (2020) Nicola Specchio et al. EPILEPSIA
- Cannabidiol efficacy and clobazam status: A systematic review and meta‐analysis
- (2020) Simona Lattanzi et al. EPILEPSIA
- Does cannabidiol have antiseizure activity independent of its interactions with clobazam? An appraisal of the evidence from randomized controlled trials
- (2020) Meir Bialer et al. EPILEPSIA
- Fenfluramine acts as a positive modulator of sigma-1 receptors
- (2020) Parthena Martin et al. EPILEPSY & BEHAVIOR
- Thrombocytopenia in pediatric patients on concurrent cannabidiol and valproic acid
- (2020) Nancy A. McNamara et al. EPILEPSIA
- Slow Titration of Cannabidiol Add-On in Drug-Resistant Epilepsies Can Improve Safety With Maintained Efficacy in an Open-Label Study
- (2020) Gianluca D'Onofrio et al. Frontiers in Neurology
- Cardiovascular safety of fenfluramine in the treatment of Dravet syndrome: Analysis of an ongoing long‐term open‐label safety extension study
- (2020) Wyman W. Lai et al. EPILEPSIA
- Efficacy and safety of Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: A real‐world study
- (2020) Nicola Specchio et al. EPILEPSIA
- Starting stiripentol in adults with Dravet syndrome? Watch for ammonia and carnitine
- (2020) Quratulain Zulfiqar Ali et al. EPILEPSIA
- Therapeutic advances in Dravet syndrome: a targeted literature review
- (2020) Adam Strzelczyk et al. Expert Review of Neurotherapeutics
- Cognitive and behavioral effects of cannabidiol in patients with treatment-resistant epilepsy
- (2020) Birgitta Metternich et al. EPILEPSY & BEHAVIOR
- Long-term safety and effectiveness of stiripentol in patients with Dravet syndrome: Interim report of a post-marketing surveillance study in Japan
- (2020) Miyuki Yamada et al. EPILEPSY RESEARCH
- Stiripentol for the treatment of seizures associated with Dravet syndrome
- (2019) Catherine Chiron Expert Review of Neurotherapeutics
- Burden-of-illness and cost-driving factors in Dravet syndrome patients and carers: A prospective, multicenter study from Germany
- (2019) Adam Strzelczyk et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Long-term safety and efficacy of cannabidiol in children and adults with treatment-resistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program results
- (2019) Linda C. Laux et al. EPILEPSY RESEARCH
- An Old Drug for a New Indication: Repurposing Fenfluramine From an Anorexigen to an Antiepileptic Drug
- (2019) An‐Sofie Schoonjans et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- A multicenter, matched case-control analysis comparing burden-of-illness in Dravet syndrome to refractory epilepsy and seizure remission in patients and caregivers in Germany
- (2019) Adam Strzelczyk et al. EPILEPSIA
- Potential Adverse Drug Events and Drug–Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use
- (2019) Joshua D. Brown et al. Journal of Clinical Medicine
- Recent Advances in the Drug Treatment of Dravet Syndrome
- (2019) Elaine C. Wirrell et al. CNS DRUGS
- Drug–drug interactions with cannabidiol (CBD) appear to have no effect on treatment response in an open-label Expanded Access Program
- (2019) Tyler E. Gaston et al. EPILEPSY & BEHAVIOR
- Seizure management and prescription patterns of anticonvulsants in Dravet syndrome: A multicenter cohort study from Germany and review of literature
- (2019) Susanne Schubert-Bast et al. EPILEPSY & BEHAVIOR
- Stiripentol: A Review in Dravet Syndrome
- (2019) James E. Frampton DRUGS
- Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial
- (2019) Lieven Lagae et al. LANCET
- Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens
- (2019) Rima Nabbout et al. JAMA Neurology
- The direct and indirect costs of Dravet Syndrome
- (2018) Melanie D. Whittington et al. EPILEPSY & BEHAVIOR
- Long-term cannabidiol treatment in patients with Dravet syndrome: An open-label extension trial
- (2018) Orrin Devinsky et al. EPILEPSIA
- Emerging drugs for the treatment of Dravet syndrome
- (2018) Francesco Brigo et al. EXPERT OPINION ON EMERGING DRUGS
- A phase I, randomized, open-label, single-dose, 3-period crossover study to evaluate the drug-drug interaction between ZX008 (fenfluramine HCl oral solution) and a regimen of stiripentol, clobazam, and valproate in healthy subjects
- (2018) Brooks Boyd et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Caregiver impact and health service use in high and low severity Dravet syndrome: A multinational cohort study
- (2018) Lieven Lagae et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Dravet syndrome: Characteristics, comorbidities, and caregiver concerns
- (2017) Nicole Villas et al. EPILEPSY & BEHAVIOR
- Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
- (2017) Orrin Devinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Audit of use of stiripentol in adults with Dravet syndrome
- (2016) S. Balestrini et al. ACTA NEUROLOGICA SCANDINAVICA
- Efficacy of antiepileptic drugs for the treatment of Dravet syndrome with different genotypes
- (2016) Xiu-Yu Shi et al. BRAIN & DEVELOPMENT
- Five-year extended follow-up status of 10 patients with Dravet syndrome treated with fenfluramine
- (2016) Berten Ceulemans et al. EPILEPSIA
- Clinical implications ofSCN1Amissense and truncation variants in a large Japanese cohort with Dravet syndrome
- (2016) Atsushi Ishii et al. EPILEPSIA
- Mortality in Dravet syndrome: A review
- (2016) Sharon Shmuely et al. EPILEPSY & BEHAVIOR
- Patients with dravet syndrome in the era of stiripentol: A French cohort cross-sectional study
- (2016) Paola De Liso et al. EPILEPSY RESEARCH
- Clobazam: A Safe, Efficacious, and Newly Rediscovered Therapeutic for Epilepsy
- (2015) Angela C. Gauthier et al. CNS Neuroscience & Therapeutics
- Moving beyond evidence-based medicine: Incorporating patient values and preferences
- (2015) Aria Fallah EPILEPSY & BEHAVIOR
- The European patient with Dravet syndrome: Results from a parent-reported survey on antiepileptic drug use in the European population with Dravet syndrome
- (2015) Luis Miguel Aras et al. EPILEPSY & BEHAVIOR
- Efficacy and tolerability of the ketogenic diet in Dravet syndrome – Comparison with various standard antiepileptic drug regimen
- (2015) Anastasia Dressler et al. EPILEPSY RESEARCH
- Long-term safety and efficacy of stiripentol for the treatment of Dravet syndrome: A multicenter, open-label study in Japan
- (2015) Yushi Inoue et al. EPILEPSY RESEARCH
- Stable dosages of clobazam for Lennox-Gastaut syndrome are associated with sustained drop-seizure and total-seizure improvements over 3 years
- (2014) Joan A. Conry et al. EPILEPSIA
- Evaluation of health-care utilization in patients with Dravet syndrome and on adjunctive treatment with stiripentol and clobazam
- (2014) Adam Strzelczyk et al. EPILEPSY & BEHAVIOR
- Effectiveness of add-on stiripentol to clobazam and valproate in Japanese patients with Dravet syndrome: Additional supportive evidence
- (2014) Yushi Inoue et al. EPILEPSY RESEARCH
- Stiripentol in Dravet syndrome: Results of a retrospective U.S. study
- (2013) Elaine C. Wirrell et al. EPILEPSIA
- Encephalopathy in children with Dravet syndrome is not a pure consequence of epilepsy
- (2013) Rima Nabbout et al. Orphanet Journal of Rare Diseases
- Prognostic, clinical and demographic features in SCN1A mutation-positive Dravet syndrome
- (2012) A. Brunklaus et al. BRAIN
- Successful use of fenfluramine as an add-on treatment for Dravet syndrome
- (2012) Berten Ceulemans et al. EPILEPSIA
- Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: Initial monotherapy outcomes at 12 months
- (2012) Tracy A. Glauser et al. EPILEPSIA
- Bromide in Patients with SCN1A-Mutations Manifesting as Dravet Syndrome
- (2012) Jan Lotte et al. NEUROPEDIATRICS
- Concentrations of Stiripentol in Children and Adults With Epilepsy
- (2012) Theodor W. May et al. THERAPEUTIC DRUG MONITORING
- The core Dravet syndrome phenotype
- (2011) Charlotte Dravet EPILEPSIA
- Interactions between modulators of the GABAA receptor: Stiripentol and benzodiazepines
- (2011) Janet L. Fisher EUROPEAN JOURNAL OF PHARMACOLOGY
- Randomized, phase III study results of clobazam in Lennox-Gastaut syndrome
- (2011) Y. T. Ng et al. NEUROLOGY
- Dravet syndrome: Patients with co-morbid SCN1A gene mutations and mitochondrial electron transport chain defects
- (2011) Alexa K. Craig et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Medical Management of Lennox-Gastaut Syndrome
- (2010) Aspasia Michoulas et al. CNS DRUGS
- NaV1.1 channels and epilepsy
- (2010) William A. Catterall et al. JOURNAL OF PHYSIOLOGY-LONDON
- Ethosuximide, Valproic Acid, and Lamotrigine in Childhood Absence Epilepsy
- (2010) Tracy A. Glauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dravet syndrome: Early clinical manifestations and cognitive outcome in 37 Italian patients
- (2009) Francesca Ragona et al. BRAIN & DEVELOPMENT
- Stiripentol open study in Japanese patients with Dravet syndrome
- (2009) Yushi Inoue et al. EPILEPSIA
- Digenic mutations in severe myoclonic epilepsy of infancy
- (2009) Maija Bolszak et al. EPILEPSY RESEARCH
- Sodium valproate: an old drug with new roles
- (2009) Natalia N. Nalivaeva et al. TRENDS IN PHARMACOLOGICAL SCIENCES
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started